Adastra Pharmaceuticals Overview

  • Founded
  • 2005
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $2.25M
Latest Deal Amount
  • Investors
  • 8

Adastra Pharmaceuticals General Information

Description

Developer of proprietary medicines designed to offer treatment for cancer. The company's medicines include an oral multi-kinase inhibitor which combines the benefits of inhibiting important cyclin-dependent kinases equipotently, enabling healthcare professional to ensure better survival of their patients and increase their quality of life.

Contact Information

Website
www.adastrarx.com
Formerly Known As
Tragara Pharmaceuticals, Inc., Tragara Pharmaceuticals Inc
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 12481 High Bluff Drive
  • Suite 150
  • San Diego, CA 92130
  • United States
+1 (760) 000-0000

Adastra Pharmaceuticals Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Adastra Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series B) 12-Apr-2019 $2.25M 000.00 0000 Completed Clinical Trials - Phase 1
8. Later Stage VC (Series A) 15-Nov-2016 00.000 000.00 000.00 Completed Product Development
7. Later Stage VC (Series 3) 01-Sep-2015 000.00 000.00 000.00 Completed Product Development
6. Later Stage VC (Series 2) 03-Sep-2013 0000 0000 000.00 Completed Product Development
5. Early Stage VC (Series 1) 08-Aug-2012 000 0000 0000 Completed Product Development
4. Grant 26-Mar-2010 000 0000 Completed Product Development
3. Early Stage VC (Series 1) 04-Feb-2010 000 0000 0000 Completed Product Development
2. Early Stage VC (Series 1) 15-Mar-2007 $40M $48M 0000 Completed Startup
1. Early Stage VC 29-Dec-2006 $8M $8M Completed Startup
To view Adastra Pharmaceuticals’s complete valuation and funding history, request access »

Adastra Pharmaceuticals Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.00
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series 3 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series 2 3,199,449 $0.000100 $0.32 $4 $4 1x $4 11.24%
Series 1 4,374,998 $0.000100 8% $10 $10 1x $10 15.37%
To view Adastra Pharmaceuticals’s complete cap table history, request access »

Adastra Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of proprietary medicines designed to offer treatment for cancer. The company's medicines include an oral multi
Drug Discovery
San Diego, CA
3 As of 2019
000.00
000 0000-00-00
00000000000 000.00

000000 0

ulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mo
0000 000000000
Malvern, PA
00 As of 0000
00000
0000 0000-00-00
00000000 00000

00000000

olor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore mag
0000 000000000
Saint Louis, MO
00.000
0000000000 0 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Adastra Pharmaceuticals Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Galera Therapeutics Formerly VC-backed Malvern, PA 00 00000 00000000 00000
00000000 Venture Capital-Backed Saint Louis, MO 00.000 0000000000 0 00.000
000000000 Corporate Backed or Acquired Gaithersburg, MD 00 000.00 000000 - 000 000.00
0000000000 0000000 Angel-Backed Ann Arbor, MI 0 00000 000000000. 0 00000
0000000 Formerly PE-Backed Hayward, CA 00 00000 0000000000.
To view Adastra Pharmaceuticals’s complete competitors history, request access »

Adastra Pharmaceuticals Executive Team (11)

Name Title Board Seat Contact Info
Scott Megaffin Chief Executive Officer & Board Member
Lynne Rollins Chief Financial Officer
Tracy Lawhon JD Chief Operating Officer
Thomas Estok Co-Founder & Board Member
Jillian Chapas-Reed Vice President of Clinical Operations
You’re viewing 5 of 11 executive team members. Get the full list »

Adastra Pharmaceuticals Board Members (13)

Name Representing Role Since
Alain Schreiber MD ProQuest Investments Board Member 000 0000
Dennis Podlesak Domain Associates Board Member 000 0000
Eckard Weber MD Domain Associates Board Member 000 0000
Grigory Borisenko Adastra Pharmaceuticals Board Member 000 0000
Mauro Bove Self Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Adastra Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Adastra Pharmaceuticals Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Lightstone Ventures Venture Capital Minority 000 0000 000000 0
RusnanoMedInvest Venture Capital Minority 000 0000 000000 0
Multiple Myeloma Research Foundation Corporation Minority 000 0000 000000 0
Mitsubishi International Corporation Minority 000 0000 000000 0
Morgenthaler Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial